previous compound ID: 818 next compound
InChIKey: HDWIHXWEUNVBIY-UHFFFAOYSA-N
SMILES: C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "D Rotin" "E Matthes" "J Liao" "DY Thomas" "GW Carlile" "J Goepp" "SD Macknight" "JW Hanrahan" "B Kus"

chemical graph of compound 818





CID is 2315
synonyms found at PubChem are:
BENDROFLUMETHIAZIDE, Bendrofluazide, 73-48-3, Naturetin, Aprinox, Benzhydroflumethiazide, Benzylrodiuran, Berkozide, Centyl, Pluryl, Neo-naclex, Bentride, Bristuric, Bristuron, Flumesil, Niagaril, Plusuril, Poliuron, Sinesalin, Sodiuretic, Thiazidico, Benuron, Intolex, Livesan, Nikion, Orsile, Pluryle, Repicin, Salural, Salures, Urlea, Benzylhydroflumethiazide, Neo-rontyl, Relan beta, BHFT, Bendroflumethiazidum, Corzide, Rauzide, Benzydroflumethiazide, bendrofumethiazide, Bendroflumetiazida, Rautrax N, Naturetin-2.5, Naturine, Bendroflumethazide, Flumersil, Naigaril, Nateretin, Bendroflumethiazidum [INN-Latin], Bendroflumetiazida [INN-Spanish], Benzy-rodiuran, Bendroflumetiazide, NATURETIN-5, NATURETIN-10, Be 724-A, Bendroflumetiazide [DCIT], BL H368, FT 8, Bendroflumethiazide [USP], FT 81, Naturetin (TN), HSDB 3293, C15H14F3N3O4S2, EINECS 200-800-1, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide, BRN 0373316, 3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine, 1,1-dioxide, MLS000028558, CHEBI:3013, Bendroflumethiazide (JAN/USP/INN), 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-benzyl-3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide, 3-Benzyl-6-trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine, 1,1-dioxide, SMR000058802, Bendroflumethiazide-d5, DSSTox_CID_2647, DSSTox_RID_76673, DSSTox_GSID_22647, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-benzyl-3,4-dihydro-6-(trifluoromethyl)-,1,1-dioxide, 3-Benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6-trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide, (+-)-3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide, (+-)-, 3-(phenylmethyl)-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide, SR-01000000103, NeoNaClex, Bendroflumethiazid, CAS-73-48-3, benzidroflumetiazide, Relan .beta., NCGC00016312-01, 3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1?^{6},2,4-benzothiadiazine-7-sulfonamide, Prestwick_992, Behenic Fatty Acids, rac Bendroflumethiazide, Bendroflumethiazide [USP:INN:BAN:JAN], Spectrum_001386, AC1L1DEI, Opera_ID_1043, Prestwick0_000784, Prestwick1_000784, Prestwick2_000784, Prestwick3_000784, Spectrum2_001524, Spectrum3_001558, Spectrum4_000774, Spectrum5_001016, D02PAH, CHEMBL1684, SCHEMBL26016, BSPBio_000888, BSPBio_003036, KBioGR_001188, KBioSS_001866, 4-27-00-08041 (Beilstein Handbook Reference), MLS001076062, MLS002548857, DivK1c_000274, SPECTRUM1503104, SPBio_001308, SPBio_002827, (.+/-.)-Bendroflumethiazide, BPBio1_000978, GTPL7122, DTXSID5022647, CTK8F7951, HMS500N16, KBio1_000274, KBio2_001866, KBio2_004434, KBio2_007002, KBio3_002536, HDWIHXWEUNVBIY-UHFFFAOYSA-N, MolPort-003-666-443, NINDS_000274, HMS1570M10, HMS1922E15, HMS2092J16, HMS2097M10, HMS2230G10, HMS3259D17, HMS3370I20, HMS3714M10, Pharmakon1600-01503104, BCP24525, Tox21_110365, 2259AH, CCG-39302, NSC758229, AKOS024255718, Tox21_110365_1, AN-5774, API0001605, Bendroflumethiazide, analytical standard, DB00436, HS-0095, MCULE-7811865125, NC00664, NSC-758229, IDI1_000274, NCGC00018194-02, NCGC00018194-03, NCGC00018194-04, NCGC00018194-08, NCGC00089729-02, NCGC00089729-03, 3,4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 4CN-1235, CPD000058802, LS-40431, SAM002264598, SBI-0051772.P002, AB00052315, EU-0009291, FT-0662517, ST51014919, UNM000000601501, C07758, D00650, AB00052315_15, AB00052315_16, 073B483, SR-01000000103-2, SR-01000000103-4, BRD-A80017228-001-05-9, BRD-A80017228-001-15-8, Z2786051551, Bendroflumethiazide, British Pharmacopoeia (BP) Reference Standard, Bendroflumethiazide, European Pharmacopoeia (EP) Reference Standard, Bendroflumethiazide, United States Pharmacopeia (USP) Reference Standard, 1,1-dioxo-3-benzyl-6-(trifluoromethyl)-2H,3H,4H-benzo[e]1,2,4-thiadiazine-7-su lfonamide, 3-Benzyl-6-trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide, 3-Benzyl-6-trifluoromethyl-7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide, (+-)-3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide, 2H-1,2,4-Benzothiadiazine-7-sulfonamide,3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide, 3,4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide, 3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide, 3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide, 3-Benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #, 3-benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide, 96782-79-5